Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Image credit: Kukula-Koch W, Szwajgier D, Gawe-Bben K, Strzpek-Gomka M, Gowniak K, Meissner HO
Deutsches rzteblatt International, 118 (49), 84756
It does not appear on the Drug Product Database as an approved therapeutic
A 2024 systematic review concluded that "clinical data were limited, and in-human safety remains unknown." The majority of supportive data comes from animal models
Combining multiple neuroprotective drugs or treatments often yields superior outcomes compared to single-agent approaches
Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL
US$ 26.53
US$ 29.20
US$ 20.18
US$ 29.11
US$ 26.05
US$ 28.07
US$ 27.29
US$ 26.10
